Risk-weighted apoB
Biomarker1 paper1 finding
- Humans1
Effects
1Reclassification of atherogenic particle burden
upin humans1
1 study
Reclassification of atherogenic particle burden
upin humans1
Risk-weighted apoB increases reclassification of atherogenic particle burden in humans (60.0% reclassified by ≥ 10 percentile points).
Humansin a real-world Lp(a)-enriched cohort
The hidden atherogenic burden of lipoprotein(a): Reclassification by risk-weighted apoB in a multicenter registry · Atherosclerosis · 18 Aug 2026